Cranbrook Wealth Management’s Novo Nordisk NVO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-110	Closed	-$9.46K	–	449
2024 Q4	$9.46K	Buy	110 +100	+1,000%	+$8.6K	﹤0.01%	271
2024 Q3	$1.19K	Buy	+10	New	+$1.19K	﹤0.01%	341